Product review on the Anti-PD-L1 Antibody Atezolizumab.

about

Product review on the Anti-PD-L1 Antibody Atezolizumab.

Item

http://www.wikidata.org/entity/Q45074483

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Product review on the Anti-PD-L1 Antibody Atezolizumab.

@en

Product review on the Anti-PD-L1 Antibody Atezolizumab.

@nl

type

Item

label

Product review on the Anti-PD-L1 Antibody Atezolizumab.

@en

Product review on the Anti-PD-L1 Antibody Atezolizumab.

@nl

prefLabel

Product review on the Anti-PD-L1 Antibody Atezolizumab.

@en

Product review on the Anti-PD-L1 Antibody Atezolizumab.

@nl

P1476

Product review on the Anti-PD-L1 Antibody Atezolizumab.

@en

P2093

Alexander Spira

http://www.w3.org/2001/XMLSchema#string

Karin Choquette

http://www.w3.org/2001/XMLSchema#string

Neil J Shah

http://www.w3.org/2001/XMLSchema#string

William J Kelly

http://www.w3.org/2001/XMLSchema#string

P2860

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Immuno-oncology combinations: a review of clinical experience and future prospects

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/21645515.2017.1403694

http://www.w3.org/2001/XMLSchema#string

P50

Stephen V Liu

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194007

http://www.w3.org/2001/XMLSchema#string

P921

Atezolizumab

P932

5806639

http://www.w3.org/2001/XMLSchema#string